Multicentric investigations of the role in the disease severity of accelerated phospholipid changes in COVID-19 patient airway - Institut des Sciences du Vivant Frédéric JOLIOT Accéder directement au contenu
Article Dans Une Revue Microbes and Infection Année : 2024

Multicentric investigations of the role in the disease severity of accelerated phospholipid changes in COVID-19 patient airway

Résumé

Context. The changes in host membrane phospholipids are crucial in airway infection pathogenesis. Phospholipase A2 hydrolyzes host cell membranes, producing lyso-phospholipids and free fatty acids, including arachidonic acid (AA), which contributes significantly to lung inflammation. Aim. Follow these changes and their evolution from day 1, day 3 to day 7 in airway aspirates of 89 patients with COVID-19-associated acute respiratory distress syndrome and examine whether they correlate with the severity of the disease. The patients were recruited in three French intensive care units. The analysis was conducted from admission to the intensive care unit until the end of the first week of mechanical ventilation. Results. In the airway aspirates, we found significant increases in the levels of host cell phospholipids, including phosphatidyl-serine and phosphatidyl-ethanolamine, and their corresponding lyso-phospholipids. This was accompanied by increased levels of AA and its inflammatory metabolite prostaglandin E2 (PGE2). Additionally, enhanced levels of ceramides, sphingomyelin, and free cholesterol were observed in these aspirates. These lipids are known to be involved in cell death and/or apoptosis, whereas free cholesterol plays a role in virus entry and replication in host cells. However, there were no significant changes in the levels of dipalmitoyl-phosphatidylcholine, the major surfactant phospholipid. A correlation analysis revealed an association between mortality risk and levels of AA and PGE2, as well as host cell phospholipids. Conclusion. Our findings indicate a correlation between heightened cellular phospholipid modifications and variations in AA and PGE2 with the severity of the disease in patients. Nevertheless, there is no indication of surfactant alteration in the initial phases of the illness.
Fichier principal
Vignette du fichier
Mitri et al HAL 2024.pdf (2.05 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04585505 , version 1 (23-05-2024)

Identifiants

Citer

Christie Mitri, François Philippart, Emmanuelle Sacco, Stéphane Legriel, Nathalie Rousselet, et al.. Multicentric investigations of the role in the disease severity of accelerated phospholipid changes in COVID-19 patient airway. Microbes and Infection, 2024, 2024, pp.105354. ⟨10.1016/j.micinf.2024.105354⟩. ⟨hal-04585505⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More